Industry News
Pharmaceutical Industry News
Some Pharmacies Are Offering Unauthorized Ozempic Alternatives
Regulators are raising concerns about compounded semaglutide.
A U.S. Experiment on Single-Payer Care Just Ended
The system for one disease, Covid, had similarities to “Medicare for all.”
Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptiva
Los asesores de la FDA afirman que los beneficios superan sus riesgos. La agencia decidirá si en pocos meses el anticonceptivo podrá venderse sin receta en Estados Unidos.
What to Know About the New Treatment for Hot Flashes
Veozah, a nonhormonal drug, is effective against a signature symptom of menopause.
FDA Approves New Drug to Treat Hot Flashes
It is the first nonhormonal treatment for the menopause symptom.
Big Pharma Is Avoiding Taxes, and Trump’s Tax Reforms Made It Worse
Tax avoidance is a drug on the market.
Public Health Lessons Learned From the Coronavirus Pandemic
The United States’ struggle to respond to the virus has highlighted the importance of communicating with the public, sharing data and stockpiling vital supplies.
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Finds
Black patients with opioid use disorder were far less likely to fill prescriptions for the most effective addiction treatments than white patients. But strikingly few patients of all races got the medicine.
What an Over-the-Counter Birth Control Pill Could Mean for You
F.D.A. advisers voted that the benefits of a nonprescription pill outweigh the risks. If the agency decides to move on the recommendation, the progestin-only contraceptive could be in stores within a few months.
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.
As Covid Emergency Ends, U.S. Response Shifts to Peacetime Mode
The coronavirus public health emergency, declared by the Trump administration in 2020, will expire on Thursday. Interviews with senior health officials suggest the nation is not ready for a new pandemic.
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
The panel will vote Wednesday on whether the risks outweigh the benefits. The company says the tablet, Opill, is safe and easy to use but F.D.A. scientists have concerns about the data.
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEP
A jury sided with Gilead Sciences in a dispute over whether the government could claim a share of profits from drugs seen as crucial to ending the H.I.V. epidemic.
The Drug That Saves Lives Even if It’s Never Used
Just handling Narcan and learning how to use it changes the way people think about drug addiction.
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.
RSV Vaccine Approved for Older Adults
The shots would be the first vaccines available against a respiratory virus that kills thousands and leads to many more hospitalizations each year.
National Academies Members Demand Answers About Sacklers’ Donations
The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.
Biden Is Running on His Record as President. Here’s Where He Stands.
President Biden has acknowledged that he has not accomplished all he wished to. But that, he maintains, is an argument for his re-election.
FDA Approves Biogen’s Drug for Rare Form of ALS
The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.
Can Africa Get Close to Vaccine Independence? Here’s What It Will Take.
Leaders on the continent have vowed that if there is another pandemic, they won’t be shut out of the vaccine market.